Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon

被引:49
作者
De Kanter, R
Monshouwer, M
Draaisma, AL
De Jager, MH
De Graaf, IAM
Proost, JH
Meijer, DKF
Groothuis, GMM
机构
[1] Grp Pfizer Inc, Pharmacia Italia SpA, Dept Pharmacokinet Dynam & Metab, I-20014 Nerviano, MI, Italy
[2] Univ Groningen, Inst Drug Explorat GUIDE, Dept Pharmacokinet & Drug Delivery, NL-9713 AV Groningen, Netherlands
关键词
D O I
10.1080/004982502000196758
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The aim was to investigate whether precision-cut rat tissue slices could be used to predict metabolic drug clearance ill vivo. To obtain a complete picture, slices not only from liver, but also from lung, kidney, small intestine and colon were included. 2. The metabolic clearances of 7-ethoxycoumarin, 7-hydroxycoumarin, testosterone, methyltestosterone and warfarin were determined by measuring the disappearance of these compounds during incubation with slices prepared from liver, lung, kidney, small intestine and colon. 3. The total ill vitro metabolic clearance was determined by adding the individual ill vitro organ clearances from the slices. Prediction based on the ill vitro clearance was within an order of magnitude to the corresponding ill vivo values. Interestingly, the relative contribution of extrahepatic metabolic clearance of the studied compounds to total clearance was remarkably high, ranging from 35 to 72% of the total metabolic clearance. 4. It is concluded that the model of multi-organ precision-cut slices is a useful in vitro tool for prediction of ill vivo metabolic clearance. In addition, it provides information about the relative contribution of the liver, lung, kidney, small intestine and colon to the total metabolic clearance.
引用
收藏
页码:229 / 241
页数:13
相关论文
共 39 条
[1]  
Andersson TB, 2001, DRUG METAB DISPOS, V29, P712
[2]  
Carlile DJ, 1998, DRUG METAB DISPOS, V26, P216
[3]  
Carlile DJ, 1999, DRUG METAB DISPOS, V27, P526
[4]   Utility of metabolic stability screening:: comparison of in vitro and in vivo clearance [J].
Clarke, SE ;
Jeffrey, P .
XENOBIOTICA, 2001, 31 (8-9) :591-598
[5]   Comparison of in vitro preparations for semi-quantitative prediction of in vivo drug metabolism [J].
De Graaf, IAM ;
Van Meijeren, CE ;
Pektas, F ;
Koster, HJ .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) :1129-1136
[6]   A rapid and simple method for cryopreservation of human liver slices [J].
de Kanter, R ;
Olinga, P ;
Hof, I ;
de Jager, M ;
Verwillegen, WA ;
Slooff, MJH ;
Koster, HJ ;
Meijer, DKF ;
Groothuis, GMM .
XENOBIOTICA, 1998, 28 (03) :225-234
[7]  
de Kanter R, 2002, CURR DRUG METAB, V3, P39
[8]   Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices [J].
De Kanter, R ;
De Jager, MH ;
Draaisma, AL ;
Jurva, JU ;
Olinga, P ;
Meijer, DKF ;
Groothuis, GMM .
XENOBIOTICA, 2002, 32 (05) :349-362
[9]   Organ slices as an in vitro test system for drug metabolism in human liver, lung and kidney [J].
de Kanter, R ;
Olinga, P ;
de Jager, MH ;
Merema, MT ;
Meijer, DKF ;
Groothius, GMM .
TOXICOLOGY IN VITRO, 1999, 13 (4-5) :737-744
[10]  
EKINS S, 1995, DRUG METAB DISPOS, V23, P1274